Data shows drug slowing Alzheimer's but doubts over effect remain | Health News
Lecanemab modestly slows disease’s inevitable worsening, but it remains unclear how much of a difference it will make.
Stay updated with breaking news from Bart De Strooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lecanemab modestly slows disease’s inevitable worsening, but it remains unclear how much of a difference it will make.
An experimental treatment for Alzheimer's disease developed by Eisai and Biogen has slowed the decline of cognitive abilities in patients who participated in a clinical trial, according to...
Experts hailed full data Wednesday showing a new drug can slow cognitive decline in Alzheimer's patients, but warned improvements were comparatively small and the treatment can have serious side effects.
Muna Therapeutics has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research.
LifeArc and the UK Dementia Research Institute (UK DRI) have today launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia, which around 900,000 people in the UK are living with.